Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Syncona has equipped Resolution with funding to explore a restorative liver therapy based on the research of Edinburgh's Prof Stuart Forbes.

Syncona, Jeito Capital and EcoR1 Capital have co-led the Netherlands Cancer Institute-founded Neogene Therapeutics' series A round.

Accor Group, Groupe Monnoyeur and Thélem Assurances have all backed marine hydrogen generator and fuel business EODev, an offshoot of Energy Observer.

State Farm Ventures and existing investor Bloomberg Beta helped the call centre technology provider close a round that will support R&D and hiring.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Alexandria Venture Investments contributed to a $91.5m round for Korro, which is working on RNA therapies for liver, eye and central nervous system diseases.

Wu Capital has led a series A round for Korro Bio, whose RNA editing technology was developed at UChicago-affiliated Marine Biological Laboratory.

Greenlight Re-backed business health insurance provider Sana secured $20.8m to take its funding to more than $27m altogether.